Multi-marker Approach for Risk Assessment in PAH
NCT03954405 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-04-13
Summary
Prospective registry including incident patients and prevalent patients which pretends to identify clinical characteristics, treatment trends in-hospital and ten years follow-up outcome through major adverse cardiovascular events (MACE) in a China population with well characterized PAH.
Conditions
Sponsors & Collaborators
-
Wuhan Asia Heart Hospital
lead OTHER
Principal Investigators
-
Qiu Qiu · Wuhan Asian Heart Hospital
Eligibility
- Min Age
- 1 Year
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-01
- Primary Completion
- 2023-12-30
- Completion
- 2025-12-30
Countries
- China
Study Locations
More Related Trials
-
Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension
NCT02885155 ·Status: COMPLETED
-
Performance of Pulmonary Embolism Risk Scores Out Come in CTPA Confirmed Patients
NCT05613855 ·Status: UNKNOWN
-
Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension
NCT05861479 ·Status: COMPLETED
-
Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies
NCT02959723 ·Status: UNKNOWN
-
Screening of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers
NCT01600898 ·Status: COMPLETED
-
The Study Of CT Scans and Echo Parameters in Patients With PAH
NCT00625963 ·Status: COMPLETED
-
Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
NCT01717092 ·Status: UNKNOWN
-
Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension
NCT01572077 ·Status: COMPLETED ·Phase: NA
-
The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD
NCT02267200 ·Status: COMPLETED
-
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
NCT03195543 ·Status: UNKNOWN
-
Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension
NCT03134898 ·Status: COMPLETED
-
Right Ventricular Metabolism in Pulmonary Arterial Hypertension
NCT02763735 ·Status: COMPLETED
-
Serum Bio-markers in Pulmonary Hypertension
NCT04472533 ·Status: COMPLETED
-
PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
NCT06998329 ·Status: RECRUITING
-
Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome
NCT02565030 ·Status: COMPLETED
-
Evaluation of Antithrombotic STrategies in STEMI Patients in China
NCT03510832 ·Status: UNKNOWN
-
Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases
NCT02777957 ·Status: UNKNOWN
-
Pulmonary Endarterectomy Guided by CT Scanning for Patients With Chronic Thromboembolic Pulmonary Hypertension----PEACT
NCT03795740 ·Status: UNKNOWN ·Phase: NA
-
Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China
NCT03185377 ·Status: UNKNOWN
-
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
NCT05618093 ·Status: WITHDRAWN ·Phase: NA
-
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
NCT01607489 ·Status: COMPLETED ·Phase: NA
-
Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans
NCT00621075 ·Status: COMPLETED
-
Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)
NCT05745961 ·Status: RECRUITING
-
The Prospective Risk Factor Evaluation & Discovery In CTEPH Study
NCT03470207 ·Status: UNKNOWN ·Phase: NA
-
Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases
NCT00909467 ·Status: COMPLETED